Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rader

Showing results (511-520 of 1,026) with videos related to

Pageof 103
Sort By:
Human Gene Therapy|September 19, 2012
Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemiaSadik H Kassim, Hui Li, Peter Bell, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2026
Evaluation of the genome-informed risk assessment (GIRA) approach from eMERGE in an independent health systemSandra Lapinska, Xinzhe Li, Ravi Mandla, et al.
Nature Communications|March 22, 2021
Disrupting upstream translation in mRNAs is associated with human diseaseDavid S M Lee, Joseph Park, Andrew Kromer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2010
Influence of apolipoprotein A-I domain structure on macrophage reverse cholesterol transport in miceEric T Alexander, Charulatha Vedhachalam, Sandhya Sankaranarayanan, et al.
Journal of Lipid Research|April 7, 1999
Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic miceH Hosoai, N R Webb, J M Glick, et al.
Circulation. Cardiovascular Quality and Outcomes|July 24, 2019
Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular OutcomesKelly D Myers, Niloofar Farboodi, Mkaya Mwamburi, et al.
Journal of Lipid Research|May 10, 2006
Substrate specificity of lipoprotein lipase and endothelial lipase: studies of lid chimerasNathalie Griffon, Elaine C Budreck, Christopher J Long, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 20, 2021
A Genome-First Approach to Rare Variants in Dominant Postlingual Hearing Loss Genes in a Large Adult PopulationShadi Ahmadmehrabi, Binglan Li, Daniel Hui, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 7, 2007
Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and effluxGinny L Weibel, Eric T Alexander, Michelle R Joshi, et al.
Circulation. Genomic and Precision Medicine|July 11, 2018
Multiplexed Targeted Resequencing Identifies Coding and Regulatory Variation Underlying Phenotypic Extremes of High-Density Lipoprotein Cholesterol in HumansSumeet A Khetarpal, Paul L Babb, Wei Zhao, et al.
Pageof 103

Showing results (511-520 of 1,026) with videos related to

Sort By:
Pageof 103
Human Gene Therapy|September 19, 2012
Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemiaSadik H Kassim, Hui Li, Peter Bell, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2026
Evaluation of the genome-informed risk assessment (GIRA) approach from eMERGE in an independent health systemSandra Lapinska, Xinzhe Li, Ravi Mandla, et al.
Nature Communications|March 22, 2021
Disrupting upstream translation in mRNAs is associated with human diseaseDavid S M Lee, Joseph Park, Andrew Kromer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2010
Influence of apolipoprotein A-I domain structure on macrophage reverse cholesterol transport in miceEric T Alexander, Charulatha Vedhachalam, Sandhya Sankaranarayanan, et al.
Journal of Lipid Research|April 7, 1999
Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic miceH Hosoai, N R Webb, J M Glick, et al.
Circulation. Cardiovascular Quality and Outcomes|July 24, 2019
Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular OutcomesKelly D Myers, Niloofar Farboodi, Mkaya Mwamburi, et al.
Journal of Lipid Research|May 10, 2006
Substrate specificity of lipoprotein lipase and endothelial lipase: studies of lid chimerasNathalie Griffon, Elaine C Budreck, Christopher J Long, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 20, 2021
A Genome-First Approach to Rare Variants in Dominant Postlingual Hearing Loss Genes in a Large Adult PopulationShadi Ahmadmehrabi, Binglan Li, Daniel Hui, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 7, 2007
Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and effluxGinny L Weibel, Eric T Alexander, Michelle R Joshi, et al.
Circulation. Genomic and Precision Medicine|July 11, 2018
Multiplexed Targeted Resequencing Identifies Coding and Regulatory Variation Underlying Phenotypic Extremes of High-Density Lipoprotein Cholesterol in HumansSumeet A Khetarpal, Paul L Babb, Wei Zhao, et al.
Pageof 103